National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

This is VAERS ID 1486330



Case Details

VAERS ID: 1486330 (history)  
Form: Version 2.0  
Age: 28.0  
Sex: Female  
Location: Oregon  
Vaccinated:2021-07-01
Onset:2021-07-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-07-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0196 / 1 LA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Contusion, Feeling abnormal, Headache, Rash, Vaccination site mass, Vertigo, Vision blurred
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Dementia (broad), Accidents and injuries (narrow), Glaucoma (broad), Lens disorders (broad), Retinal disorders (broad), Vestibular disorders (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ESTRADIOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19 (Covid Prior Vaccination? Yes)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021869039

Write-up: Vertigo/room spinning; Blurry vision; General "fuzzy" head feeling; Headache going from back of head (left side) to the front.; Had a small rash that has since turned into the bruise; Had a small rash that has since turned into the bruise; Bruised knot at injection site still hasn''t cleared; This is a spontaneous report from a contactable other healthcare professional (patient). A 28-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0196) via an unspecified route of administration, in the left arm on 01Jul2021 (at the age of 28-years-old) as dose 1, single for COVID-19 immunization at pharmacy or drug store. The patient medical history included covid-19 from an unknown date and unknown if ongoing. Concomitant medication within 2 weeks of vaccination included ESTRADIOL, 0.5mg once daily taken for an unspecified indication, start and stop date were not reported. Allergies to medications, food, or other products included dilaudid and lortab. Prior to vaccination patient was diagnosed with COVID-19 and did not received any other vaccines within 4 weeks. Since the vaccination, the patient had not been tested for COVID-19. On 01Jul2021, the patient experienced headache going from back of head (left side) to the front started within an hour of receiving the vaccine and hadn''t stopped since, and Still ongoing; and also had Bruised knot at injection site still hadn''t cleared and had a small rash that has since turned into the bruise. On 03Jul2021, on day 3 after vaccine patient had Vertigo including blurry vision, room spinning, and general fuzzy head feeling started and lasted until day 7. The reporter assessed the events as non-serious The patient did not receive any treatment for the event. Outcome of the events vertigo, blurry vision and general fuzzy head feeling was recovered on 07Jul2021 and outcome of other events was not recovered.


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1486330


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166